Variant report

Variant	esv3325286
Chromosome Location	chr3:154796483-154799031
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:144)
CpG islands
(count:1040)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:144 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:154797474-154798778	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr3:154796747-154796753	K562	blood:	n/a	n/a
3	BHLHE40	chr3:154796861-154796873	K562	blood:	n/a	n/a
4	BHLHE40	chr3:154797570-154798230	K562	blood:	n/a	n/a
5	CCNT2	chr3:154797526-154798068	K562	blood:	n/a	n/a
6	CHD1	chr3:154797947-154798281	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD1	chr3:154797021-154797201	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD2	chr3:154797668-154798209	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTBP2	chr3:154797512-154798221	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr3:154797058-154797272	K562	blood:	n/a	n/a
11	CTCF	chr3:154797600-154797750	AG04449	skin:	n/a	n/a
12	CTCF	chr3:154797980-154798130	HBMEC	blood vessel:	n/a	n/a
13	CTCF	chr3:154797320-154797470	AG04449	skin:	n/a	n/a
14	CTCF	chr3:154797240-154797390	SK-N-SH_RA	brain:	n/a	n/a
15	CTCF	chr3:154796960-154797110	AG09309	skin:	n/a	n/a
16	CTCF	chr3:154797120-154797270	AG04450	lung:	n/a	n/a
17	CTCF	chr3:154797180-154797330	HAc	cerebellar:	n/a	n/a
18	CTCF	chr3:154797260-154797410	AoAF	blood vessel:	n/a	n/a
19	CTCF	chr3:154797220-154797370	HMF	breast:	n/a	n/a
20	CTCF	chr3:154797220-154797370	HUVEC	blood vessel:	n/a	n/a
21	CTCF	chr3:154797298-154797422	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr3:154797260-154797410	HBMEC	blood vessel:	n/a	n/a
23	CTCF	chr3:154797220-154797370	HVMF	connective:	n/a	n/a
24	CTCF	chr3:154797260-154797410	HMEC	breast:	n/a	n/a
25	CTCF	chr3:154797240-154797390	HPF	lung:	n/a	n/a
26	CTCF	chr3:154797260-154797410	AG09319	gingival:	n/a	n/a
27	CTCF	chr3:154797340-154797490	WERI-Rb-1	eye:	n/a	n/a
28	CTCF	chr3:154797240-154797390	HBMEC	blood vessel:	n/a	n/a
29	CTCF	chr3:154797300-154797450	AG04449	skin:	n/a	n/a
30	CTCF	chr3:154797060-154797210	NHLF	lung:	n/a	n/a
31	CTCF	chr3:154797260-154797410	BJ	skin:	n/a	n/a
32	CTCF	chr3:154797240-154797390	HPAF	blood vessel:	n/a	n/a
33	CTCF	chr3:154797240-154797390	AoAF	blood vessel:	n/a	n/a
34	CTCF	chr3:154797280-154797430	HVMF	connective:	n/a	n/a
35	CTCF	chr3:154797260-154797410	K562	blood:	n/a	n/a
36	CTCF	chr3:154797240-154797390	AG09309	skin:	n/a	n/a
37	CTCF	chr3:154797240-154797390	AG10803	skin:	n/a	n/a
38	CTCF	chr3:154797040-154797190	HFF	foreskin:	n/a	n/a
39	CTCF	chr3:154797260-154797410	HMF	breast:	n/a	n/a
40	CTCF	chr3:154797220-154797370	HPF	lung:	n/a	n/a
41	CTCF	chr3:154796860-154797130	AG04450	lung:	n/a	n/a
42	CTCF	chr3:154797240-154797390	AG09319	gingival:	n/a	n/a
43	CTCF	chr3:154797000-154797150	HPF	lung:	n/a	n/a
44	CTCF	chr3:154797260-154797410	HCFaa	heart:	n/a	n/a
45	CTCF	chr3:154797280-154797430	NHDF-neo	bronchial:	n/a	n/a
46	CTCF	chr3:154797160-154797310	HFF-Myc	foreskin:	n/a	n/a
47	CTCF	chr3:154797820-154797970	SK-N-SH_RA	brain:	n/a	chr3:154797904-154797917
48	CTCF	chr3:154798500-154798650	HCPEpiC	choroid plexus:	n/a	n/a
49	CTCF	chr3:154797240-154797390	AG04450	lung:	n/a	n/a
50	CTCF	chr3:154797280-154797430	HCM	heart:	n/a	n/a

(count:1040 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:154797947-154797997	NHBE	bronchial:	n/a
2	chr3:154797958-154798008	HCPEpiC	choroid plexus:	n/a
3	chr3:154797917-154797967	HEK293	kidney:	embryo
4	chr3:154797947-154797997	NHBE	bronchial:	n/a
5	chr3:154797958-154798008	HCPEpiC	choroid plexus:	n/a
6	chr3:154797917-154797967	HEK293	kidney:	embryo
7	chr3:154798079-154798129	GM19239	blood:	n/a
8	chr3:154797947-154797997	A549	lung:	n/a
9	chr3:154798079-154798129	AG04449	skin:	fetal
10	chr3:154797677-154797727	HMEC	breast:	n/a
11	chr3:154797947-154797997	Jurkat	blood:	n/a
12	chr3:154797677-154797727	PANC-1	pancreas:	n/a
13	chr3:154797349-154797399	GM12892	blood:	n/a
14	chr3:154797677-154797727	HRCEpiC	kidney:	n/a
15	chr3:154797083-154797133	Hela-S3	cervix:	n/a
16	chr3:154797892-154797942	GM19239	blood:	n/a
17	chr3:154797947-154797997	BJ	skin:	n/a
18	chr3:154796861-154796911	PFSK-1	brain:	n/a
19	chr3:154797958-154798008	AG09319	gingival:	n/a
20	chr3:154797399-154797449	HPAEpiC	pulmonary alveolar:	n/a
21	chr3:154797947-154797997	U87	brain:	n/a
22	chr3:154797779-154797829	T-47D	breast:	n/a
23	chr3:154797589-154797639	HCF	heart:	n/a
24	chr3:154797592-154797642	HAEpiC	amniotic membrane:	n/a
25	chr3:154797083-154797133	ECC-1	luminal epithelium:	n/a
26	chr3:154797958-154798008	GM06990	blood:	n/a
27	chr3:154797947-154797997	HAEpiC	amniotic membrane:	n/a
28	chr3:154797563-154797613	HCT-116	colon:	n/a
29	chr3:154797947-154797997	K562	blood:	n/a
30	chr3:154797563-154797613	HRE	kidney:	n/a
31	chr3:154797592-154797642	T-47D	breast:	n/a
32	chr3:154796861-154796911	NHDF-neo	bronchial:	n/a
33	chr3:154797589-154797639	AoSMC	blood vessel:	n/a
34	chr3:154796861-154796911	GM06990	blood:	n/a
35	chr3:154797589-154797639	AG09309	skin:	n/a
36	chr3:154797563-154797613	Hepatocyte	liver:	n/a
37	chr3:154797958-154798008	Caco-2	colon:	n/a
38	chr3:154798079-154798129	PrEC	prostate:	n/a
39	chr3:154797867-154797917	HPAEpiC	pulmonary alveolar:	n/a
40	chr3:154797892-154797942	Caco-2	colon:	n/a
41	chr3:154797349-154797399	Hepatocyte	liver:	n/a
42	chr3:154797349-154797399	HCT-116	colon:	n/a
43	chr3:154797592-154797642	GM12878	blood:	n/a
44	chr3:154797399-154797449	HEK293	kidney:	embryo
45	chr3:154797563-154797613	GM12878	blood:	n/a
46	chr3:154797349-154797399	HCM	heart:	n/a
47	chr3:154797399-154797449	U87	brain:	n/a
48	chr3:154797508-154797558	SK-N-MC	brain:	n/a
49	chr3:154797589-154797639	Caco-2	colon:	n/a
50	chr3:154797867-154797917	HCM	heart:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr3:154788960..154792081-chr3:154794108..154796605,3	MCF-7	breast:
2	chr3:154794372..154796771-chr3:154800533..154803148,2	MCF-7	breast:

No data

Variant related genes	Relation type
MME	TF binding region
MME	CpG island
ENSG00000196549	chromatin interactions

Extended variants
information (count: 96 )
Associated
traits (count: 51 )

Variant overlapped rSNPs/rCNVs (count:96 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562637520	chr3:154796507-154796508	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs534397076	chr3:154796543-154796544	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs546706816	chr3:154796587-154796588	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs533157278	chr3:154796603-154796604	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs551319988	chr3:154796623-154796624	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs149539086	chr3:154796633-154796634	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs35900633	chr3:154796645-154796646	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs144095312	chr3:154796680-154796681	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs549630106	chr3:154796681-154796682	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs1836912	chr3:154796689-154796690	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs538432526	chr3:154796731-154796732	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs148617721	chr3:154796735-154796736	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs568927838	chr3:154796783-154796784	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs539451497	chr3:154796790-154796791	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs557754801	chr3:154796810-154796811	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs573115721	chr3:154796820-154796821	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs533873516	chr3:154796899-154796900	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs371630621	chr3:154796932-154796933	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs555623858	chr3:154796948-154796949	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs573797504	chr3:154796975-154796976	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs543954263	chr3:154796997-154796998	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs183316815	chr3:154797012-154797013	Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs187507869	chr3:154797030-154797031	Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs575183945	chr3:154797134-154797135	Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs545022663	chr3:154797141-154797142	Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs560313287	chr3:154797153-154797154	Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs112682496	chr3:154797182-154797183	Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs549452993	chr3:154797248-154797249	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs373602047	chr3:154797255-154797256	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs555476269	chr3:154797306-154797307	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs574009094	chr3:154797321-154797322	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs73874497	chr3:154797386-154797387	Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs539514715	chr3:154797418-154797419	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs201751860	chr3:154797425-154797426	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs377303426	chr3:154797427-154797428	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs202082495	chr3:154797428-154797429	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs9864458	chr3:154797432-154797433	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs551437913	chr3:154797520-154797521	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs566382653	chr3:154797595-154797596	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs533777704	chr3:154797641-154797642	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs192718956	chr3:154797693-154797694	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs371601308	chr3:154797750-154797751	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs567181239	chr3:154797768-154797769	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs537664389	chr3:154797791-154797792	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
45	rs555911647	chr3:154797860-154797861	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs35599824	chr3:154797878-154797879	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
47	rs375270621	chr3:154797915-154797916	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs577393872	chr3:154797950-154797951	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs545132235	chr3:154798058-154798059	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs368302087	chr3:154798072-154798073	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:51)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Neurodevelopmental disorder	22521361	CNVD
Bladder cancer	21909424	CNVD
Ovarian clear cell carcinoma	21343371	CNVD

Chromatin state (count:392 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:154789000-154796600	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr3:154789200-154797400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr3:154789600-154796600	Weak transcription	HSMMtube	muscle
4	chr3:154795000-154796600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
5	chr3:154795200-154796600	Weak transcription	K562	blood
6	chr3:154795800-154796600	Bivalent Enhancer	Fetal Brain Male	brain
7	chr3:154796000-154796600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr3:154796000-154796800	Flanking Active TSS	NHDF-Ad	bronchial
9	chr3:154796000-154802200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
10	chr3:154796200-154799600	Active TSS	ES-I3 Cell Line	embryonic stem cell
11	chr3:154796200-154799600	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr3:154796400-154796600	Active TSS	H1 Cell Line	embryonic stem cell
13	chr3:154796400-154796600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
14	chr3:154796400-154796600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
15	chr3:154796400-154796600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
16	chr3:154796400-154796600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
17	chr3:154796400-154796600	Active TSS	Primary B cells from cord blood	blood
18	chr3:154796400-154796600	Active TSS	Primary hematopoietic stem cells	blood
19	chr3:154796400-154796600	Enhancers	Primary hematopoietic stem cells short term culture	blood
20	chr3:154796400-154796600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
21	chr3:154796400-154796600	Bivalent/Poised TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
22	chr3:154796400-154796600	Active TSS	Adipose Nuclei	Adipose
23	chr3:154796400-154796600	Flanking Bivalent TSS/Enh	Fetal Lung	lung
24	chr3:154796400-154796600	Enhancers	HMEC	breast
25	chr3:154796400-154796600	Enhancers	HSMM	muscle
26	chr3:154796400-154796600	Enhancers	HUVEC	blood vessel
27	chr3:154796400-154796800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
28	chr3:154796400-154796800	Active TSS	Brain Anterior Caudate	brain
29	chr3:154796400-154796800	Flanking Active TSS	Fetal Kidney	kidney
30	chr3:154796400-154797000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
31	chr3:154796400-154797000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
32	chr3:154796400-154797200	Flanking Active TSS	Dnd41	blood
33	chr3:154796400-154797200	Flanking Active TSS	Osteobl	bone
34	chr3:154796400-154799000	Active TSS	Placenta Amnion	Placenta Amnion
35	chr3:154796400-154799200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
36	chr3:154796400-154800000	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr3:154796400-154800000	Active TSS	NHLF	lung
38	chr3:154796600-154796800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
39	chr3:154796600-154796800	Flanking Bivalent TSS/Enh	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr3:154796600-154796800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
41	chr3:154796600-154796800	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
42	chr3:154796600-154796800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
43	chr3:154796600-154796800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
44	chr3:154796600-154796800	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
45	chr3:154796600-154796800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr3:154796600-154796800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
47	chr3:154796600-154796800	Enhancers	Liver	Liver
48	chr3:154796600-154796800	Bivalent/Poised TSS	Brain Angular Gyrus	brain
49	chr3:154796600-154796800	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
50	chr3:154796600-154796800	Flanking Bivalent TSS/Enh	Brain Inferior Temporal Lobe	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links